Videos

Luis A. Diaz, M.D., head of the division of Solid Tumors at Memorial Sloan Kettering Cancer Center, discusses response rates in patients with microsatellite instability-high (MSI-H) or NTRK fusion gastrointestinal (GI) cancers.

Mark Heaney, M.D., Ph.D., Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, discusses the pros and cons of patients with myeloproliferative neoplasms (MPNs) researching their diagnosis online.

Catriona Jamieson, M.D., Ph.D., Professor of Medicine, University of California, San Diego Health Moores Cancer Center, discusses what people diagnosed with myeloproliferative neoplasms (MPN) need to consider when choosing among providers and treatment options.

Gabriela Hobbs, M.D., discusses how to manage symptoms associated with a myeloproliferative neoplasm diagnosis.

Lindsey M. Lyle, M.S., offers advice to patients with newly diagnosed myeloproliferative neoplasms.

Barbara Abernathy, Ph.D., CEO of the Pediatric Oncology Support Team, explains how she is inspired by her work with children who have cancer.

Martha Raymond, founder and CEO of the Raymond Foundation, discusses how her organization helps to provide a voice for patients with gastrointestinal (GI) cancers.

Julia Nangia, M.D., assistant professor at Baylor College of Medicine, discusses the impact that chemotherapy-related hair loss can have on patients with breast cancer.